BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27601918)

  • 1. Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma.
    Guo H; Xing Y; Mu A; Li X; Li T; Bian X; Yang C; Zhang X; Liu Y; Wang X
    Onco Targets Ther; 2016; 9():5257-70. PubMed ID: 27601918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. -216G/T (rs712829), a functional variant of the
    Guo H; Xing Y; Liu R; Chen S; Bian X; Wang F; Yang C; Wang X
    Oncol Lett; 2013 Sep; 6(3):693-698. PubMed ID: 24137392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
    Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
    PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI.
    Jung M; Cho BC; Lee CH; Park HS; Kang YA; Kim SK; Chang J; Kim DJ; Rha SY; Kim JH; Lee JH
    Yonsei Med J; 2012 Nov; 53(6):1128-35. PubMed ID: 23074112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
    Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
    BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Epidermal Growth Factor Receptor Single Nucleotide Polymorphisms and Radiochemotherapy Response in Cervical Cancer.
    Jin G; Fan XM; Li KX; Niu SH; Zhang QY
    Pathol Oncol Res; 2020 Apr; 26(2):1255-1261. PubMed ID: 31254173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.
    Nie Q; Yang XN; An SJ; Zhang XC; Yang JJ; Zhong WZ; Liao RQ; Chen ZH; Su J; Xie Z; Wu YL
    Eur J Cancer; 2011 Sep; 47(13):1962-70. PubMed ID: 21616658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
    Liu W; Wu X; Zhang W; Montenegro RC; Fackenthal DL; Spitz JA; Huff LM; Innocenti F; Das S; Cook EH; Cox NJ; Bates SE; Ratain MJ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6788-95. PubMed ID: 18006781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome.
    Gao LB; Zhou B; Zhang L; Wei YS; Wang YY; Liang WB; Lv ML; Pan XM; Chen YC; Rao L
    BMC Med Genet; 2008 Jul; 9():74. PubMed ID: 18664296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer.
    Ichihara S; Toyooka S; Fujiwara Y; Hotta K; Shigematsu H; Tokumo M; Soh J; Asano H; Ichimura K; Aoe K; Aoe M; Kiura K; Shimizu K; Date H; Shimizu N
    Int J Cancer; 2007 Mar; 120(6):1239-47. PubMed ID: 17192902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population.
    Torres-Jasso JH; Marín ME; Santiago-Luna E; Leoner JC; Torres J; Magaña-Torres MT; Perea FJ; Ibarra B; Sánchez-López JY
    Genet Mol Res; 2015 Mar; 14(1):1802-7. PubMed ID: 25867325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients.
    Shitara M; Sasaki H; Yokota K; Okuda K; Hikosaka Y; Moriyama S; Yano M; Kawaguchi T; Kubo A; Takada M; Kitahara N; Okumura M; Matsumura A; Iuchi K; Fujii Y
    Exp Ther Med; 2012 Nov; 4(5):785-789. PubMed ID: 23226726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro.
    Puyo S; Le Morvan V; Robert J
    Mol Diagn Ther; 2008; 12(4):225-34. PubMed ID: 18652519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions.
    Liu W; He L; Ramírez J; Krishnaswamy S; Kanteti R; Wang YC; Salgia R; Ratain MJ
    Cancer Res; 2011 Apr; 71(7):2423-7. PubMed ID: 21292812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
    Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.
    Liu G; Gurubhagavatula S; Zhou W; Wang Z; Yeap BY; Asomaning K; Su L; Heist R; Lynch TJ; Christiani DC
    Pharmacogenomics J; 2008 Apr; 8(2):129-38. PubMed ID: 17375033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer.
    Milano G; Etienne-Grimaldi MC; Dahan L; Francoual M; Spano JP; Benchimol D; Chazal M; Letoublon C; André T; Gilly FN; Delpero JR; Formento JL
    Ann Oncol; 2008 Dec; 19(12):2033-8. PubMed ID: 18632722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
    Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
    Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
    Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The status of EGFR CA SSR1 is a potential prognostic factor for patients with oral squamous cell carcinoma.
    Lin YL; Wang WY; Lin JC; Wong YK; Chien YC
    Oral Oncol; 2011 Jun; 47(6):482-6. PubMed ID: 21530363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.